Value of drug or valuable drug: a point of view issue

Authors

  • Francesca Patarnello Payers and Evidence Solution Director, Access to Medicine. GlaxoSmithKline Spa – Pharmaceuticals, Verona, Italy

DOI:

https://doi.org/10.7175/fe.v13i4.329

Keywords:

Drugs, Value, Costs, Pharmacoeconomics

Downloads

Published

2012-12-15

Issue

Section

Editorial

How to Cite

1.
Patarnello F. Value of drug or valuable drug: a point of view issue. FE. 2012;13(4):155-157. doi:10.7175/fe.v13i4.329